SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-12-000012
Filing Date
2012-03-09
Accepted
2012-03-09 15:21:07
Documents
21
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k_2011.htm 10-K 2395791
2 exhibit10-11.htm EX-10.11 156247
3 exhibit10-17.htm EX-10.17 593
4 exhibit10_17.jpg GRAPHIC 220817
5 exhibit10-18.htm EX-10.18 682
6 exhibit10_18.jpg GRAPHIC 214684
7 exhibit10-46.htm EX-10.46 76083
8 exhibit10-45.htm EX-10.45 28100
9 exhibit10-47.htm EX-10.47 58268
10 exhibit21-1.htm EX-20.1 13342
11 exhibit23_1.htm EX-23.1 6022
12 exhibit31_1.htm EX-31.1 9922
13 exhibit31_2.htm EX-31.2 11187
14 exhibit32_1.htm EX-32.1 4371
15 exhibit32_2.htm EX-32.2 4742
  Complete submission text file 0001367644-12-000012.txt   7468706

Data Files

Seq Description Document Type Size
16 ebs-20111231.xml EX-101.INS 945996
17 ebs-20111231.xsd EX-101.SCH 21235
18 ebs-20111231_cal.xml EX-101.CAL 57155
19 ebs-20111231_def.xml EX-101.DEF 23030
20 ebs-20111231_lab.xml EX-101.LAB 251096
21 ebs-20111231_pre.xml EX-101.PRE 136978
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 12680400
SIC: 2834 Pharmaceutical Preparations